Which of the following is a quantitative defect in globin synthesis
Wait, the options aren't given, but the correct answer is missing. The user probably wants me to figure out the correct answer based on the question. Let me think. Quantitative defects mean there's a problem with the amount of globin produced. That's different from qualitative defects, which are about the structure of the globin chains.
So, beta-thalassemia is a classic example of a quantitative defect because it's due to reduced or absent beta-globin production. On the other hand, sickle cell anemia is a qualitative defect where the beta-globin is structurally abnormal. Thalassemias are all about reduced synthesis. Alpha-thalassemia is also quantitative but affects alpha-globin.
So the correct answer here should be beta-thalassemia. Let me verify. The question asks for a quantitative defect in globin synthesis. Beta-thalassemia is caused by mutations in the beta-globin gene leading to decreased production. That fits. The other options might include conditions like sickle cell (qualitative), or maybe other anemias. So the answer is beta-thalassemia. Now I need to structure the explanation as per the user's instructions.
**Core Concept**
Quantitative defects in globin synthesis refer to disorders where the production of alpha or beta-globin chains is reduced, leading to imbalanced hemoglobin formation. These are distinct from qualitative defects (e.g., sickle cell disease), where globin structure is abnormal. Beta-thalassemia and alpha-thalassemia are classic examples.
**Why the Correct Answer is Right**
Beta-thalassemia results from mutations in the **HBB gene**, causing decreased or absent beta-globin synthesis. This leads to excess alpha-globin chains precipitating in red blood cells, causing hemolysis and anemia. The "quantitative" defect stems from reduced production, not structural abnormalities. Genetic mechanisms include point mutations, deletions, or promoter defects in the beta-globin locus.
**Why Each Wrong Option is Incorrect**
**Option A:** Sickle cell anemia is a *qualitative* defect (abnormal beta-globin structure, not reduced synthesis).
**Option B:** Iron-deficiency anemia involves heme deficiency, not globin chain synthesis.
**Option C:** G6PD deficiency is an enzyme defect in red cell metabolism, unrelated to globin synthesis.
**Option D:** Hereditary spherocytosis is a membrane defect causing hemolysis, not linked to globin chain production.
**Clinical Pearl**
Remember: **"Thalassemia = -emia (excess globin chains)"**. Beta-thalassemia reduces beta-globin β excess alpha; alpha-thalassemia reduces alpha β excess beta. Differentiate from sickle cell (structural mutation) using hemoglobin electrophoresis.
**Correct Answer: B. Beta-thalassem